| Particulars |
|
|
|
| Company Name
| Novartis India Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
12.35 |
B.V. (₹) |
313.90 |
| Sales(₹ Cr.) |
390.09 |
NP (₹ Cr.) |
100.82 |
| NP Var% |
21.00 |
Div% |
500.00 |
| CPS(₹) |
41.70 |
EPS (₹) |
40.80 |
| Traded Value(₹ Lakhs) |
355.52 |
52 Week High |
1,100.00 |
| 52 Week Low |
748.00 |
Price BSE |
1,028.00 |
| Price NSE |
672.00 |
Market Capital (₹ Cr.) |
2,537.60 |
| P/C Ratio |
24.60 |
P/E Ratio |
25.20 |
| Price Vs.BV |
3.27 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
85.90 |
| NP(₹ Cr.) |
16.09 |
NP Var % |
-37.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
345.11 |
| OPM |
21.13 |
NP |
87.40 |
| NP Var% |
12.69 |
EPS |
39.38 |
| PE |
26.10 |
|
|